Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,111) with videos related to
Page
of 112
Sort By:
The New England Journal of Medicine
|
July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Chirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
American Journal of Medical Genetics. Part A
|
August 29, 2018
Variable Clinical Manifestations of Xia-Gibbs syndrome: Findings of Consecutively Identified Cases at a Single Children's Hospital
Alyssa L Ritter, Carey McDougall, Cara Skraban, et al.
Circulation
|
May 11, 2012
Multisite randomized trial of a single-session versus multisession literacy-sensitive self-care intervention for patients with heart failure
Darren A DeWalt, Dean Schillinger, Bernice Ruo, et al.
JAMA Ophthalmology
|
November 26, 2015
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A Wells, Adam R Glassman, Lee M Jampol, et al.
Science Translational Medicine
|
July 3, 2020
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients
Joseph L Mann, Caitlin L Maikawa, Anton A A Smith, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2024
Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients
Jordan K Mah, Patrick C K Tam, Yeh-Chung Chang, et al.
JAMA
|
November 14, 2015
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
, Jeffrey G Gross, Adam R Glassman, et al.
The New England Journal of Medicine
|
February 19, 2015
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
, John A Wells, Adam R Glassman, et al.
Lancet Regional Health. Americas
|
August 21, 2023
Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium
Christine M Durand, Nina Martinez, Karl Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Paul G Richardson, Shaji K Kumar, Tamás Masszi, et al.
Page
of 112
Search research articles
Search
Showing results (1051-1060 of 1,111) with videos related to
Sort By:
Page
of 112
The New England Journal of Medicine
|
July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Chirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
American Journal of Medical Genetics. Part A
|
August 29, 2018
Variable Clinical Manifestations of Xia-Gibbs syndrome: Findings of Consecutively Identified Cases at a Single Children's Hospital
Alyssa L Ritter, Carey McDougall, Cara Skraban, et al.
Circulation
|
May 11, 2012
Multisite randomized trial of a single-session versus multisession literacy-sensitive self-care intervention for patients with heart failure
Darren A DeWalt, Dean Schillinger, Bernice Ruo, et al.
JAMA Ophthalmology
|
November 26, 2015
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A Wells, Adam R Glassman, Lee M Jampol, et al.
Science Translational Medicine
|
July 3, 2020
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients
Joseph L Mann, Caitlin L Maikawa, Anton A A Smith, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 19, 2024
Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients
Jordan K Mah, Patrick C K Tam, Yeh-Chung Chang, et al.
JAMA
|
November 14, 2015
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
, Jeffrey G Gross, Adam R Glassman, et al.
The New England Journal of Medicine
|
February 19, 2015
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
, John A Wells, Adam R Glassman, et al.
Lancet Regional Health. Americas
|
August 21, 2023
Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium
Christine M Durand, Nina Martinez, Karl Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Paul G Richardson, Shaji K Kumar, Tamás Masszi, et al.
Page
of 112